Sarcopenia is associated with survival in patients with urothelial carcinoma treated with systemic chemotherapy

被引：0
|
作者：
Ryutaro Shimizu
Masashi Honda
Shogo Teraoka
Tetsuya Yumioka
Noriya Yamaguchi
Bunya Kawamoto
Hideto Iwamoto
Shuichi Morizane
Katsuya Hikita
Atsushi Takenaka
机构：
[1] Tottori University,Division of Urology, Department of Surgery, Faculty of Medicine
来源：
International Journal of Clinical Oncology | 2022年 / 27卷
关键词：
Sarcopenia; Urothelial carcinoma; Prognostic factors;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：175 / 183
页数：8
相关论文
共 50 条
  • [41] SURVIVAL OUTCOMES IN PATIENTS UNDERGOING NEOADJUVANT CHEMOTHERAPY FOR UPPER TRACT UROTHELIAL CELL CARCINOMA
    Porten, Sima
    Siefker-Radtke, Arlene
    Kamat, Ashish
    Dinney, Colin
    Matin, Surena
    JOURNAL OF UROLOGY, 2013, 189 (04): : E366 - E367
  • [42] Patterns of use of perioperative chemotherapy in patients treated with radical cystectomy for urothelial carcinoma of the bladder
    Liew, M. S.
    Tafreshi, A.
    Eapen, R.
    Davis, I. D.
    Sengupta, S.
    BJU INTERNATIONAL, 2013, 111 : 71 - 71
  • [43] Effect of intensification of platinum analogue combination chemotherapy on survival in patients with advanced urothelial carcinoma
    Sengelov, L
    Nielsen, OS
    Kamby, C
    Geertsen, P
    vonderMaase, H
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 1144 - 1144
  • [44] TWO CYCLES OF NEOADJUVANT CHEMOTHERAPY IMPROVES SURVIVAL OF UPPER TRACT UROTHELIAL CARCINOMA PATIENTS
    Zennami, Kenji
    Takahara, Kiyoshi
    Fukaya, Kosuke
    Ichino, Manabu
    Fukami, Naohiko
    Sasaki, Hitomi
    Sumitomo, Makoto
    Kusaka, Mamoru
    Shiroki, Ryoichi
    JOURNAL OF UROLOGY, 2020, 203 : E1248 - E1249
  • [45] IMPACT OF VARIANT HISTOLOGY ON SURVIVAL AND RESPONSE TO CHEMOTHERAPY IN PATIENTS WITH UPPER TRACT UROTHELIAL CARCINOMA
    Sui, Wilson
    Hall, Mary E.
    Barocas, Daniel A.
    Chang, Sam S.
    Penson, David F.
    Resnick, Matthew J.
    Laviana, Aaron A.
    JOURNAL OF UROLOGY, 2020, 203 : E1251 - E1251
  • [46] Utilization of perioperative systemic chemotherapy in upper tract urothelial carcinoma
    Gin, Greg E.
    Ruel, Nora H.
    Kardos, Steven V.
    Sfakianos, John P.
    Uchio, Edward
    Lau, Clayton S.
    Yuh, Bertram E.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2017, 35 (05) : 192 - 200
  • [47] Survival outcomes in patients undergoing neoadjuvant chemotherapy for upper tract urothelial cell carcinoma
    Porten, Sima P.
    Siefker-Radtke, Arlene O.
    Kamat, Ashish M.
    Dinney, Colin P. N.
    Matin, Surena F.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [48] The role of perioperative chemotherapy for upper tract urothelial carcinoma patients treated with radical nephroureterectomy
    Ugo Pinar
    Giorgio Calleris
    Elisabeth Grobet-Jeandin
    Pietro Grande
    Daniel Benamran
    Constance Thibault
    Paolo Gontero
    Morgan Rouprêt
    Thomas Seisen
    World Journal of Urology, 2023, 41 : 3205 - 3230
  • [49] MIRNA PROFILE ASSOCIATED WITH RESPONSE TO NEOADJUVANT CHEMOTHERAPY IN PATIENTS WITH UROTHELIAL CELL CARCINOMA
    Gazquez, C.
    Mengual, L.
    Ribal, M. J.
    Fernandez, P. L.
    Lozano, J. J.
    Alcaraz, A.
    EUROPEAN UROLOGY SUPPLEMENTS, 2011, 10 (02) : 78 - 78
  • [50] SYSTEMIC CHEMOTHERAPY HAS BEEN INCREASINGLY ADOPTED FOR UROTHELIAL CARCINOMA
    Maurice, Matthew
    Zhu, Hui
    JOURNAL OF UROLOGY, 2013, 189 (04): : E588 - E588
12345